Filter Results:
(83)
Show Results For
- All HBS Web (83)
- Faculty Publications (9)
Show Results For
- All HBS Web (83)
- Faculty Publications (9)
Page 1 of 83
Results →
- April 2014 (Revised March 2018)
- Case
Texas Children's Hospital: Congenital Heart Disease Care
By: Michael E. Porter, Justin M. Bachmann and Zachary C. Landman
In 2014, Dr. Charles D. Fraser Jr., Surgeon-in-Chief of Texas Children's Hospital in Houston, was contemplating the future direction of the congenital heart disease program. The nation's largest pediatric hospital, Texas Children's was ranked by U.S. News & World... View Details
Keywords: Health Care; Congenital Heart Disease; Integrated Practice Units; Health Care and Treatment; Outcome or Result; Measurement and Metrics; Performance Improvement; Health Industry; United States; Texas
Porter, Michael E., Justin M. Bachmann, and Zachary C. Landman. "Texas Children's Hospital: Congenital Heart Disease Care." Harvard Business School Case 714-507, April 2014. (Revised March 2018.)
- October 2003 (Revised February 2010)
- Case
The Duke Heart Failure Program
By: Richard M.J. Bohmer and Laura Feldman
Duke University Health System has for the past five years operated a specialized clinic for the management of congestive heart failure, a very common and costly condition in the surrounding community. Nurse practitioners, whose work is guided by highly specified... View Details
Keywords: Health Care and Treatment; Health Disorders; Medical Specialties; Time Management; Service Delivery; Service Operations; Outcome or Result; Health Industry
Bohmer, Richard M.J., and Laura Feldman. "The Duke Heart Failure Program." Harvard Business School Case 604-033, October 2003. (Revised February 2010.)
- 11 Mar 2021
- News
Leading with Heart
early in our marriage, we lost our first daughter. She was just eight months old. Her name was Tanya. She was born with an immune disease that had no cure. And that was a very hard thing to comprehend and cope with. And then we had... View Details
- June 2023
- Case
Verve Therapeutics: Taking DNA Editing to Heart
By: Shikhar Ghosh and Shweta Bagai
Verve Therapeutics, a public biotech company based in Boston, created a novel approach to addressing cardiovascular disease (CVD) - a leading cause of deaths globally. The company's approach was a single shot treatment to permanently lower cholesterol, thus reducing... View Details
Keywords: AI; Genetic Engineering; Medicine; Health Care and Treatment; Genetics; Innovation Strategy; Business and Stakeholder Relations; Medical Specialties; Innovation and Invention; Entrepreneurship; Biotechnology Industry
Ghosh, Shikhar, and Shweta Bagai. "Verve Therapeutics: Taking DNA Editing to Heart." Harvard Business School Case 823-113, June 2023.
- 17 Nov 2003
- Research & Ideas
The Business Case for Diabetes Disease Management
study, it is the seventh leading cause of death in the U.S. Its economic burden is also high, since it is linked to other afflictions such as heart and renal disease and blindness. And, she added, one of the... View Details
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
Cytokinetics, Inc., a South San Francisco–based company that focuses on treatments for debilitating diseases that compromise muscle function, such as amyotrophic lateral sclerosis (ALS), heart failure, and... View Details
Keywords: Deborah Blagg
- January 2022 (Revised August 2022)
- Case
Hello Heart: The Next Generation of Chronic Disease Management Apps
By: Ariel D. Stern and Danielle Golan
Hello Heart, a hypertension management app debated whether to go deep and cover other heart conditions, or to expand its solution to other chronic conditions. View Details
Keywords: Health; Health Care and Treatment; Information Technology; Mobile and Wireless Technology; Analysis; Business Startups; Transition; Customer Focus and Relationships; Customer Satisfaction; Decision Making; Demographics; Design; Entrepreneurship; Venture Capital; Technological Innovation; Growth and Development Strategy; Product Launch; Product Design; Product Development; Business Strategy; Competitive Strategy; Competitive Advantage; Customization and Personalization; Business Growth and Maturation; Business Model; Strategy; Applications and Software; Health Industry; Technology Industry; Israel; United States
Stern, Ariel D., and Danielle Golan. "Hello Heart: The Next Generation of Chronic Disease Management Apps." Harvard Business School Case 622-061, January 2022. (Revised August 2022.)
- 13 Aug 2018
- Research & Ideas
Women Heart Patients Have Better Survival Odds with Women Doctors
Tempura Women having a heart attack are less likely to die if their doctor is also female, a new study shows. How much less likely? When treated for a heart attack by men, the risk for women goes up 1.5... View Details
- 11 May 2011
- News
A New Era of Entrepreneurship
- 10 Jul 2017
- News
Holistic care teams can finally revolutionize healthcare
- January 2016
- Article
Incorporating Longitudinal Pediatric Patient-centered Outcome Measurement into the Clinical Workflow Using a Commercial Electronic Health Record: A Step Toward Increasing Value for the Patient
By: Kathleen Carberry, Zachary Landman, Michelle Xie, Thomas W. Feeley, John Henderson and Charles Fraser Jr.
Patient-centered outcomes measurement provides healthcare organizations with crucial information for increasing value for patients; however, organizations have struggled to obtain outcomes data from electronic health record (EHR) systems. This study describes how Texas... View Details
Keywords: Epic; Electronic Health Records; Outcomes; Value; Patient-Centered Outcomes Measurement; Value Creation; Information Technology; Health Care and Treatment; Customer Focus and Relationships; Health Industry; Texas
Carberry, Kathleen, Zachary Landman, Michelle Xie, Thomas W. Feeley, John Henderson, and Charles Fraser Jr. "Incorporating Longitudinal Pediatric Patient-centered Outcome Measurement into the Clinical Workflow Using a Commercial Electronic Health Record: A Step Toward Increasing Value for the Patient." Journal of the American Medical Informatics Association 23, no. 1 (January 2016): 88–93. (Published first online September 16, 2015.)
- 2024
- Working Paper
Coronary Artery Bypass Grafting—Impossible to Routine: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Fabio Villa
We describe how Coronary Artery Bypass Grafting (CABG, or more popularly, “bypass”) operations
revolutionized the treatment of coronary disease (that can produce fatal heart attacks and debilitating
angina). Specifically, we chronicle the: 1) development of the... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Fabio Villa. "Coronary Artery Bypass Grafting—Impossible to Routine: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-010, July 2019. (Revised May 2024.)
- 02 Jun 2021
- Research & Ideas
A Rare Find in Health Care: A Simple Solution to Racial Inequity
are within our grasp." “Although we don’t have as much data on the quality of COVID care, I’m quite sure there are much greater quality differences across hospitals in treating COVID than heart attacks,” he says. “In Boston, the leading... View Details
- 28 Apr 2011
- News
Harvard Business School Holds 15th Annual Business Plan Contest
- 2022
- Article
Investigating the Association Between Telemedicine Use and Timely Follow-Up Care After Acute Cardiovascular Hospital Encounters
By: Mitchell Tang, A Jay Holmgren, Erin E. McElrath, Ankeet S. Bhatt, Anubodh S. Varshney, Simin Gharib Lee, Muthiah Vaduganathan, Dale S. Adler and Robert S. Huckman
Background: Telemedicine use increased dramatically during the COVID-19 pandemic; however, questions remain as to how telemedicine use impacts care.
Objectives: The purpose of this study was to examine the association of increased telemedicine use on rates of... View Details
Objectives: The purpose of this study was to examine the association of increased telemedicine use on rates of... View Details
Keywords: Health Care; Telemedicine; Health Care and Treatment; Outcome or Result; Behavior; Health Industry; United States
Tang, Mitchell, A Jay Holmgren, Erin E. McElrath, Ankeet S. Bhatt, Anubodh S. Varshney, Simin Gharib Lee, Muthiah Vaduganathan, Dale S. Adler, and Robert S. Huckman. "Investigating the Association Between Telemedicine Use and Timely Follow-Up Care After Acute Cardiovascular Hospital Encounters." JACC: Advances 1, no. 5 (2022).
- 17 Dec 2007
- Research & Ideas
The Rise of Medical Tourism
India [see article], treats indigent people from neighboring countries—Pakistan, Bangladesh, Burma—who suffer from heart disease and can't afford surgery. Treatment for them is free. The hospital is able to... View Details
- August 2003 (Revised August 2024)
- Case
Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment
By: Regina E. Herzlinger and John McDonough
Many health care innovations appear successful; but fail. This is the first case in the Innovating Health Care course that investigates how to create successful health care innovations. It is part of the first module in the course. This module focuses on how to... View Details
Keywords: Three Pillars; Industry Analysis; Health Care and Treatment; Innovation and Invention; Innovation and Management; Medical Specialties; Health Industry
Herzlinger, Regina E., and John McDonough. "Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment." Harvard Business School Case 304-009, August 2003. (Revised August 2024.)
- Web
Faculty & Advisors - MBA
Cardiovascular Disease Initiative at the Broad Institute and was professor of medicine at Harvard Medical School. For his contributions to understanding the inherited basis for cardiovascular disease, Dr. Kathiresan has been honored with... View Details
- Web
Organize Care Around Medical Conditions - Institute For Strategy And Competitiveness
treated in the IPU model. An example would be children born with heart defects. While these children have differing anatomical defects resulting in differing physiology and different treatments, what they have in common are that they have... View Details